ALAN D SCHREIBER, MD
Osteopathic Medicine at Penn Tower, Philadelphia, PA
License number
Pennsylvania MD015026E
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
3400 Penn Tower, Philadelphia, PA 19104
Phone
(215) 662-3914
Personal information
See more information about ALAN D SCHREIBER at radaris.comName
Address
Phone
164 Aspen Rd, Yardley, PA 19067
1 Patricia St, Charleroi, PA 15022
237 S 18Th St APT 18A, Philadelphia, PA 19103
2557 Partridge Dr, Pittsburgh, PA 15241
821 Westview St, Philadelphia, PA 19119
Professional information
Alan Devin Schreiber, Philadelphia PA
Specialties:
Internal Medicine, Hematology, Hematology & Oncology
Work:
Hospital of the University of PA
3400 Spruce St, Philadelphia, PA 19175
3400 Spruce St, Philadelphia, PA 19175
Education:
Yeshiva University (1967)
Method Of Treating Inflammatory Conditions With Progesterone Analogs
US Patent:
6610674, Aug 26, 2003
Filed:
Sep 8, 2000
Appl. No.:
09/658867
Inventors:
Alan D. Schreiber - Philadelphia PA
Assignee:
University of Pennsylvania - Philadelphia PA
International Classification:
A61K 3156
US Classification:
514177, 514178, 514181
Abstract:
The present invention provides methods for treating inflammatory conditions, including but not limited to, inflammatory bowel disease (ulcerative colitis, Crohns disease, and proctitis), other noninfectious, inflammatory conditions of the GI tract (microscopic colitis, allergic eosinophilic gastroenteritis, food allergies, pill induced esophagitis, celiac disease, recurrent polyps, and hemorrhoids), and psoriasis, using progesterone or progesterone analogs such as medroxyprogesterone acetate.
Methods Of Stimulating Phagocytosis
US Patent:
6475997, Nov 5, 2002
Filed:
Jun 14, 1999
Appl. No.:
09/332589
Inventors:
Alan D. Schreiber - Philadelphia PA
Jong-Gu Park - Drexel Hill PA
Jong-Gu Park - Drexel Hill PA
Assignee:
University of Pennsylvania - Philadelphia PA
International Classification:
A61K 4800
US Classification:
514 44, 536 231, 536 235, 4353201, 435325, 435455, 435458
Abstract:
The present invention relates, in general, to methods of stimulating phagocytosis and thereby combating infection and/or modulating immune complex disease, in particular, to methods of modulating the number and type of Fc receptors present on cells that normally possess such receptors, including monocytes and macrophages, as well as on cells that normally do not possess Fc receptors, such as fibroblasts, and to compounds and compositions suitable for use in such methods.
Methods Of Treating Diseases Characterized By Interactions Of Igg-Containing Immune Complexes With Macrophage Fc Receptors Using Antiestrogenic Benzothiophenes
US Patent:
5075321, Dec 24, 1991
Filed:
Feb 24, 1988
Appl. No.:
7/159714
Inventors:
Alan D. Schreiber - Philadelphia PA
Assignee:
University of Pennsylvania - Philadelphia PA
International Classification:
A16K 3156
US Classification:
514317
Abstract:
Clearance of antibody-coated cells from the circulation is modulated by administering an effective amount of certain benzothiophene derivatives, or the physiologically acceptable acid addition salts thereof. The compounds are useful in treating mammalian diseases characterized by interactions between IgG containing immune complexes and macrophage Fc receptors.
Method Of Treating Inflammatory Conditions With Progesterone Or Progesterone Analogs
US Patent:
2004003, Feb 26, 2004
Filed:
Jun 24, 2003
Appl. No.:
10/601756
Inventors:
Alan Schreiber - Philadelphia PA, US
Assignee:
UNIVERSITY OF PENNSYLVANIA
International Classification:
A61K031/57
US Classification:
514/177000
Abstract:
The present invention provides methods for treating inflammatory conditions, including but not limited to, inflammatory bowel disease (ulcerative colitis, Crohn's disease, and proctitis), other noninfectious, inflammatory conditions of the GI tract (microscopic colitis, allergic eosinophilic gastroenteritis, food allergies, pill induced esophagitis, celiac disease, recurrent polyps, and hemorrhoids), and psoriasis, using progesterone or progesterone analogs such as medroxyprogesterone acetate.
Methods Of Stimulating Phagocytosis
US Patent:
6068983, May 30, 2000
Filed:
Jul 30, 1997
Appl. No.:
8/903493
Inventors:
Alan D. Schreiber - Philadelphia PA
Jong-Gu Park - Drexel Hill PA
Jong-Gu Park - Drexel Hill PA
Assignee:
University of Pennsylvania - Philadelphia PA
International Classification:
G01N 3353
US Classification:
435 724
Abstract:
The present invention relates, in general, to methods of stimulating phagocytosis and thereby combating infection and/or modulating immune complex disease, in particular, to methods of modulating the number and type of Fc receptors present on cells that normally possess such receptors, including monocytes and macrophages, as well as on cells that normally do not possess Fc receptors, such as fibroblasts, and to compounds and compositions suitable for use in such methods.
Methods Of Stimulating Phagocytosis
US Patent:
2003013, Jul 10, 2003
Filed:
Aug 16, 2002
Appl. No.:
10/219935
Inventors:
Alan Schreiber - Philadelphia PA, US
Jong-Gu Park - Drexel Hill PA, US
Jong-Gu Park - Drexel Hill PA, US
Assignee:
UNIVERSITY OF PENNSYLVANIA
International Classification:
A61K048/00, C12N005/08, C12N015/86
US Classification:
514/044000, 435/456000, 435/372000
Abstract:
The present invention relates, in general, to methods of stimulating phagocytosis and thereby combating infection and/or modulating immune complex disease, in particular, to methods of modulating the number and type of Fc receptors present on cells that normally possess such receptors, including monocytes and macrophages, as well as on cells that normally do not possess Fc receptors, such as fibroblasts, and to compounds and compositions suitable for use in such methods.
Methods Of Inhibiting Phagocytosis
US Patent:
6242427, Jun 5, 2001
Filed:
Sep 14, 1998
Appl. No.:
9/158980
Inventors:
Alan D. Schreiber - Philadelphia PA
Jong-Gu Park - Drexel Hill PA
Jong-Gu Park - Drexel Hill PA
Assignee:
University of Pennsylvania - Philadelphia PA
International Classification:
A61K 4800, C07H 2102, C07H 2104, C12Q 168, C12N 1585
US Classification:
514 44
Abstract:
The present invention relates, in general, to methods of treating diseases resulting from interactions between immune complexes and Fc receptors. In particular, the present invention relates to methods of modulating the clearance of antibody-coated cells from the circulation by inhibiting phagocytosis and to methods of modulating the interaction of immune complexes with tissue Fc receptors. Further, the invention relates to methods of modulating the activation of immunological processes mediated by Fc receptor activation resulting from antibody-antigen/receptor interaction.
Method Of Treating Atherosclerosis
US Patent:
2005009, May 5, 2005
Filed:
Nov 29, 2004
Appl. No.:
10/998049
Inventors:
Alan Schreiber - Philadelphia PA, US
Assignee:
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - Philadelphia PA
International Classification:
A61K031/56, A61K031/55
US Classification:
514171000, 514217010
Abstract:
The present invention relates to a method of treating atherosclerosis, and to compounds and compositions suitable for use in such a method.
Inhibition Of Syk Kinase Expression
US Patent:
2012009, Apr 19, 2012
Filed:
May 3, 2011
Appl. No.:
13/067035
Inventors:
Alan D. Schreiber - Philadelphia PA, US
Zena Indik - Philadelphia PA, US
Moo-Kyung Kim - Philadelphia PA, US
Zena Indik - Philadelphia PA, US
Moo-Kyung Kim - Philadelphia PA, US
Assignee:
The Trustees of The University of Pennsylvania - Philadelphia PA
International Classification:
A61K 31/713, A61P 29/00, A61K 9/127, C12N 5/071, C07H 21/02
US Classification:
424450, 435375, 435366, 514 44 A, 536 245
Abstract:
The present invention relates, in general, to Syk kinase and, in particular, to a method of inhibiting Syk kinase expression using small interfering RNA (siRNA).